Señales en vivo de HMD.AX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 abr 2024 @ 00:50):

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel...

Stats
Volumen de hoy	396 047
Volumen promedio	147 217
Capitalización de mercado	6.55M
Próxima fecha de ganancias	( $0 ) 2024-05-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.570
ATR14	$0 (0.00%)

Hera Med Ltd Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hera Med Ltd Finanzas

Annual	2023
Ingresos:	$606 986
Beneficio Bruto:	$-300 006 (-49.43 %)
EPS:	$-0.0255

FY	2023
Ingresos:	$606 986
Beneficio Bruto:	$-300 006 (-49.43 %)
EPS:	$-0.0255

FY	2022
Ingresos:	$315 789
Beneficio Bruto:	$-314 150 (-99.48 %)
EPS:	$-0.0322

FY	2021
Ingresos:	$86 654.00
Beneficio Bruto:	$44 406.00 (51.25 %)
EPS:	$-0.0454

Financial Reports:

No articles found.

Hera Med Ltd

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregnancy monitor platform for the creation and implementation of digital health solutions for maternity care management. It also develops EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.